Human immunodeficiency virus disease in the era of HAART: a reevaluation of the mucocutaneous manifestations.
Johnson
R A
RA
Beth Israel Deaconess Medical Center, Division of Dermatology, Boston, Massachusetts, USA.
D017088:AIDS-Related Opportunistic Infections / Q000175:diagnosis / Q000628:therapy; D019380:Anti-HIV Agents / Q000009:adverse effects; D001424:Bacterial Infections / Q000188:drug therapy / Q000209:etiology; D003875:Drug Eruptions / Q000209:etiology; D015658:HIV Infections / Q000150:complications*; D015497:HIV-1; D006801:Humans; D009059:Mouth Diseases / Q000188:drug therapy / Q000209:etiology*; D009369:Neoplasms / Q000209:etiology* / Q000628:therapy; D012871:Skin Diseases / Q000209:etiology* / Q000628:therapy; D014777:Virus Diseases / Q000188:drug therapy / Q000209:etiology
D019380:Anti-HIV Agents